Finance

Beta
Lists
603590:SHA
Beijing Konruns Pharmaceutical Co Ltd
CN¥34.45
-1.57%
(-0.55) 1D
May 29, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603590...
Open
CN¥35.23
High
CN¥36.22
Low
CN¥34.10
Mkt. cap
5.57B
Avg. vol.
3.88M
Volume
4.98M
P/E ratio
32.41
52-wk high
CN¥67.98
52-wk low
CN¥28.80
EPS
CN¥1.06
Shares outstanding
160.00M
No. of employees
793
Open
CN¥35.23
High
CN¥36.22
Low
CN¥34.10
Mkt. cap
5.57B
Avg. vol.
3.88M
Volume
4.98M
P/E ratio
32.41
52-wk high
CN¥67.98
52-wk low
CN¥28.80
EPS
CN¥1.06
Shares outstanding
160.00M
No. of employees
793
News stories
From sources across the web
About Beijing Konruns Pharmaceutical Co Ltd
CEO-
Employees793
FoundedSep 3, 2003
Headquarters-
SectorPharmaceutical industry
Websitekonruns.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
248.87M
231.35M
222.90M
214.87M
Cost of goods sold
24.34M
22.91M
24.09M
21.90M
Cost of revenue
24.34M
22.91M
24.09M
21.90M
Research and development expenses
12.42M
12.30M
19.06M
13.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
148.19M
154.66M
141.77M
116.52M
Operating expense
171.02M
166.20M
167.04M
133.22M
Total operating expenses
195.36M
189.12M
191.13M
155.12M
Operating income
53.50M
42.23M
31.77M
59.75M
Other non operating income
2.47M
-14.51M
12.12M
-636.15K
EBT including unusual items
54.22M
38.44M
41.48M
58.70M
EBT excluding unusual items
64.51M
28.50M
47.88M
60.43M
Income tax expense
6.02M
475.46K
6.35M
10.19M
Effective tax rate
11.10%
1.24%
15.32%
17.36%
Other operating expenses
3.51M
113.66K
5.54M
1.21M
Net income
46.55M
36.83M
38.09M
47.21M
Net profit margin
18.70%
15.92%
17.09%
21.97%
Earnings per share
-
-
-
-
Interest and investment income
11.60M
1.19M
9.96M
3.52M
Interest expense
-1.39M
-2.08M
-2.13M
-2.20M
Net interest expenses
10.21M
-889.52K
7.84M
1.32M
Depreciation and amortization charges
-
-
-
-
EBITDA
60.17M
49.22M
39.15M
67.12M
Gain or loss from assets sale
-130.67K
130.67K
553.62K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more